NuGen Medical Devices Inc Total Assets
NuGen Medical Devices Inc total assets. Based on the latest financial reports, NuGen Medical Devices Inc (NGMD) holds total assets worth CA$3.18 Million CAD (≈ $2.30 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see NuGen Medical Devices Inc market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of NuGen Medical Devices Inc (2020–2025)
Total assets of NuGen Medical Devices Inc from 2020 to 2025. This chart illustrates how NuGen Medical Devices Inc's total assets have evolved over time, based on quarterly financial data. See NGMD share price today for real-time trading data and today's change.
NuGen Medical Devices Inc - Asset Composition Analysis
NuGen Medical Devices Inc Total Assets Breakdown (December 2025)
NuGen Medical Devices Inc total assets breakdown as of December 2025. NuGen Medical Devices Inc's total assets of CA$3.18 Million consist of 93.0% current assets and 7.0% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 73.1% |
| Accounts Receivable | CA$50.71K | 1.2% |
| Inventory | CA$498.23K | 11.6% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$13.32 Million | 310.5% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how NuGen Medical Devices Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of NuGen Medical Devices Inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: NuGen Medical Devices Inc's current assets represent 93.0% of total assets in 2025, an increase from 44.4% in 2020.
- Cash Position: Cash and equivalents constituted 73.1% of total assets in 2025, up from 1.8% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 310.0% of total assets, an increase from 54.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 310.5% of total assets.
NuGen Medical Devices Inc Competitors by Total Assets
Key competitors of NuGen Medical Devices Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩253.22 Billion |
|
Paxman AB
ST:PAX
|
Sweden | Skr487.65 Million |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
NuGen Medical Devices Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.70 | 6.23 | 0.57 |
| Quick Ratio | 0.57 | 5.86 | 0.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-1.10 Million | CA$5.85 Million | CA$-4.05 Million |
NuGen Medical Devices Inc - Advanced Valuation Insights
This section examines the relationship between NuGen Medical Devices Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 34.96 |
| Latest Market Cap to Assets Ratio | 0.57 |
| Asset Growth Rate (YoY) | -66.7% |
| Total Assets | CA$4.29 Million |
| Market Capitalization | $2.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values NuGen Medical Devices Inc's assets below their book value (0.57x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: NuGen Medical Devices Inc's assets decreased by 66.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for NuGen Medical Devices Inc (2020–2025)
The table below shows the annual total assets of NuGen Medical Devices Inc from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$4.29 Million ≈ $3.10 Million |
-66.72% |
| 2024-12-31 | CA$12.89 Million ≈ $9.33 Million |
+85.65% |
| 2023-12-31 | CA$6.95 Million ≈ $5.02 Million |
+1.41% |
| 2022-12-31 | CA$6.85 Million ≈ $4.95 Million |
-22.56% |
| 2021-12-31 | CA$8.84 Million ≈ $6.40 Million |
-39.26% |
| 2020-12-31 | CA$14.56 Million ≈ $10.53 Million |
-- |
About NuGen Medical Devices Inc
NuGen Medical Devices Inc., a specialty medical device company, engages in developing and commercializing novel drug delivery technologies in Europe, Asia, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, vaccines, veterinary, home healthcare, and others. It also provides Ins… Read more